GleamWall
中文EN

AUTL Autolus Therapeutics plc

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1730463 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY168.8%
TTM net income YoY-13.9%
TTM EPS YoY-15.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin35.8%
Operating margin-159.6%
Net margin-186.4%
FCF margin-131.1%
EBITDA margin-153.1%

Returns

ROE-174.9%
ROA-43.2%
ROIC (approx.)—
Asset turnover0.23x

Leverage & solvency

Liabilities / assets94.8%
Debt / equity0.00x
Current ratio3.72x
Interest coverage-4.79x

Cash quality & payout

Operating cash flow / net income0.69x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$75.39M$10.12M
Cost of revenue$96.37M$11.39M
Gross profit-$20.98M-$1.27M
R&D expense$117.69M$138.44M
SG&A expense$131.87M$101.72M
Operating income-$270.54M-$241.43M
Interest expense$36.67M$9.29M
Pretax income-$285.56M-$219.13M
Income tax$1.97M$1.53M
Net income-$287.53M-$220.66M
EBITDA-$262.25M-$233.87M
EPS (basic)-1.08-0.86
EPS (diluted)-1.08-0.86
Weighted avg. shares (diluted)266.14M255.16M
Balance sheet
Cash & equivalents$104.13M$228.80M
Short-term investments$196.58M$360.64M
Receivables$24.02M$15,000
Inventory$33.21M$4.14M
Current assets$435.92M$660.93M
PP&E, net$63.56M$49.55M
Intangibles$19.81M$12.37M
Total assets$589.07M$782.73M
Current liabilities$73.44M$60.74M
Total liabilities$410.94M$355.40M
Shareholders' equity$178.13M$427.32M
Cash flow statement
Operating cash flow-$283.57M-$206.27M
Capital expenditure$19.04M$22.07M
Free cash flow-$302.61M-$228.35M
Investing cash flow$158.46M-$394.55M
Financing cash flow-$4.34M$589.55M
Depreciation & amortization$8.30M$7.55M
Stock-based compensation$14.44M$15.47M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.